Sermonix Pharmaceuticals is an Ohio LLC specialty pharmaceutical.
Sermonix Pharmaceuticals has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.
Sermonix Pharmaceuticals's investors include Perceptive Advisors, Richard DeSchutter, WILD Family Office, Anthony Wild, Lodewijk de Vink.
Sermonix Pharmaceuticals is headquartered in Columbus, United States.
Sermonix Pharmaceuticals is an Ohio LLC specialty pharmaceutical.
Sermonix Pharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sermonix Pharmaceuticals — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/sermonix-pharmaceuticals. Accessed November 13, 2026.
VCBacked. (2021). Sermonix Pharmaceuticals — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/sermonix-pharmaceuticals
{{cite web |title=Sermonix Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/sermonix-pharmaceuticals |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sermonix Pharmaceuticals? Request a listing update